ICON PLC

ICLR - CIK 0001060955

Market cap$11.04 B

Rank#889

SEC filings782

ICON PLC trades as ICLR and has a market capitalization of $11.04 B, making it the #889 largest US-listed company by market value. In its fiscal 2024 annual report the company posted revenue of $8.28B, up 2.0% from the prior year and net income of $791.47M. This page tracks ICON PLC through 782 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$8.28BFY 2024

Net income (latest FY)$791.47MFY 2024

Operating cash flow (latest FY)$1.29BFY 2024

Total assets (latest FY)$16.88BFY 2024

Net margin9.6%latest FY

Financial performance

Over the last 9 fiscal years ICON PLC's revenue grew from $1.57B to $8.28B, a compound annual growth rate of 20.3%. Net profit margin compressed from 15.2% to 9.6% over the same period - every figure below comes from the company's audited annual filings.

ICLR annual revenueView details

Key statistics

Market cap: $11.04 B
Share price (derived)market cap / shares outstanding: $144.59
P/E ratio (trailing FY): 13.9
EPS (diluted)FY 2024: $9.53
Shares outstandingas of 2025-09-30: 0.08B
Total equityas of 2025-09-30: $9.33B
Return on equity: 8.5%
Long-term debtas of 2025-09-30: $2.88B

Latest filings

Filing	Type	Filed
6-K	-	2026-05-26
Insider trade	4	2026-05-15
Insider trade	4	2026-05-15
Insider trade	4	2026-05-15
SCHEDULE 13G/A	-	2026-05-15
SCHEDULE 13G/A	-	2026-05-15
SCHEDULE 13G	-	2026-05-15
SCHEDULE 13G	-	2026-05-06

Browse the full filing history (782 filings)

Recent press releases

ICON expands US early phase research capabilities with new clinic and outpatient centres2026-05-13
ICON expands US early phase research capabilities with new clinic and outpatient centres | ICON plc
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results2026-04-29
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results | ICON plc
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model2026-03-24
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model | ICON plc
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices2026-02-12
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices | ICON plc
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership2026-01-27
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership | ICON plc

Similar companies

The largest companies sharing ICON PLC's SEC industry classification (services-commercial physical & biological research).

IQVIQVIA Holdings Inc.$30.40 B ICLR vs IQV

INCYIncyte Corporation$21.23 B ICLR vs INCY

MEDPMedpace Holdings, Inc.$13.30 B ICLR vs MEDP

CRLCharles River Laboratories International, Inc.$8.97 B ICLR vs CRL

ABSIAbsci Corporation$1.04 B ICLR vs ABSI

Frequently asked questions

What is ICON PLC's market cap?

ICON PLC (ICLR) has a market capitalization of $11.04 B as of 2026-06-10, ranking #889 among US-listed companies.

How much revenue does ICON PLC make?

ICON PLC reported revenue of $8.28B for fiscal year 2024, an increase of 2.0% year over year.

Is ICON PLC profitable?

Yes. ICON PLC reported net income of $791.47M in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.